Cencora (COR) Q2 2024 Earnings
COR·Reported May 1, 2024·Before market open
Cencora reported Q2 2024 revenue of $68.4B, missed analyst consensus of $70.6B by $2.2B. Diluted EPS came in at $3.80, beat the $3.69 consensus by $0.11. Cencora reports across 2 business segments, led by U.S. Healthcare Solutions and International Healthcare Solutions.
Revenue
$68.4Bmissed by $2.2B
Consensus: $70.6BDiluted EPS
$3.80beat by $0.11
Consensus: $3.69
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Cencora's Q2 2024 earnings report.
Cencora (COR) reported Q2 2024 earnings on May 1, 2024 before market open.
Cencora reported revenue of $68.4B and diluted EPS of $3.80 for Q2 2024.
Revenue missed the consensus estimate of $70.6B by $2.2B. EPS beat the consensus estimate of $3.69 by $0.11.
You can read the 10-Q periodic report (0001140859-24-000072) directly on SEC EDGAR. The filing index links above go to sec.gov.